Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights"Creative Biolabs is committed to providing highly customized comprehensive solutions with the best quality to advance our global clients’ projects."
The solute carrier family 27 of fatty acid transport protein is also known as FATPs. Although FATPs have sequence similarity, these proteins are differentially expressed in a variety of tissues and cell types (liver, skeletal muscle, adipose tissue, heart, intestine, skin, and endothelial cells, etc.). Research of gain- and loss-of-function demonstrate the categorical role of FATPs in the regulation of LCFA uptake. However, the precise mechanism by which FATPs play a role in LCFA uptake remains controversial. FATPs have been proposed as direct transporters of LCFA, as enzymes that activate LCFA by intrinsic acyl-CoA synthetase (ACS) activity, or as bifunctional proteins with independent transport and enzymatic activity. FATP1 (SLC27A1) is the first FATP identified based on its ability to increase LCFA uptake when overexpressed in cells. In addition to their role in fatty acid uptake, it is also shown that FATPs display ACS activity. The ACS enzyme catalyzes the conversion of LCFA to acyl-CoA thioester to activate LCFA. Studies examining the subcellular localization of FATPs support the role of the proteins in fatty acid uptake and activation. FATP can be present in both the plasma membrane and intracellular spaces. The identification of FATPs and cytoplasm in the plasma membrane confirmed their roles as bifunctional proteins in the fatty acid uptake and activation.
The SLC27 gene family is comprised of six members, SLC27A1-SLC27A6, which encode FATP1- FATP6.
Aided by cutting-edge MemDX™ membrane protein production platform, Creative Biolabs is proud to offer the preparation of these targets in required formats using various strategies, such as detergent micelles, proteoliposomes, nanodiscs, MP-VLPs, polymers, stable cell line.
Meanwhile, our MemDX™ membrane protein antibody discovery platform can help to discover antibodies against these targets, even fully humanized antibodies, by various approaches including hybridoma technology, phage display technology, etc. We also present DNA immunization service for anti-membrane protein antibody development. Please feel free to contact us for more information.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.